Product
Azopt®
Name
Azopt
INN Name
brinzolamide
FDA Approved
Yes
1 clinical trial
1 organization
2 indications
1 document
Indication
Primary Open Angle GlaucomaIndication
ocular hypertensionClinical trial
Therapeutic Equivalence Study of Generic Brinzolamide 1% Ophthalmic Suspension Compared to Reference Listed Drug Azopt® (Brinzolamide) Ophthalmic Suspension 1% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension.Status: Completed, Estimated PCD: 2022-12-29
Document
DailyMed Label: AzoptOrganization
Novartis Pharmaceuticals Corporation